These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30694437)

  • 1. Indirect pharmacodynamic models for responses with circadian removal.
    Ayyar VS; Krzyzanski W; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):89-101. PubMed ID: 30694437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling effect of a γ-secretase inhibitor on amyloid-β dynamics reveals significant role of an amyloid clearance mechanism.
    Das R; Nachbar RB; Edelstein-Keshet L; Saltzman JS; Wiener MC; Bagchi A; Bailey J; Coombs D; Simon AJ; Hargreaves RJ; Cook JJ
    Bull Math Biol; 2011 Jan; 73(1):230-47. PubMed ID: 20411345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
    Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
    Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
    Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
    FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
    Sun J; Zhang X; Wang C; Teng Z; Li Y
    Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
    Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
    Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative pharmacokinetic/pharmacodynamic analyses suggest that the 129/SVE mouse is a suitable preclinical pharmacology model for identifying small-molecule γ-secretase inhibitors.
    Lu Y; Zhang L; Nolan CE; Becker SL; Atchison K; Robshaw AE; Pustilnik LR; Osgood SM; Miller EH; Stepan AF; Subramanyam C; Efremov I; Hallgren AJ; Riddell D
    J Pharmacol Exp Ther; 2011 Dec; 339(3):922-34. PubMed ID: 21930801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coriandrum sativum Suppresses Aβ42-Induced ROS Increases, Glial Cell Proliferation, and ERK Activation.
    Liu QF; Jeong H; Lee JH; Hong YK; Oh Y; Kim YM; Suh YS; Bang S; Yun HS; Lee K; Cho SM; Lee SB; Jeon S; Chin YW; Koo BS; Cho KS
    Am J Chin Med; 2016; 44(7):1325-1347. PubMed ID: 27776428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ordinary differential equation approximation of gamma distributed delay model.
    Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):53-63. PubMed ID: 30617672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking.
    Ito K; Tatebe T; Suzuki K; Hirayama T; Hayakawa M; Kubo H; Tomita T; Makino M
    Eur J Pharmacol; 2017 Mar; 798():16-25. PubMed ID: 28167259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation.
    Hu J; Lin T; Gao Y; Xu J; Jiang C; Wang G; Bu G; Xu H; Chen H; Zhang YW
    PLoS One; 2015; 10(1):e0115973. PubMed ID: 25629409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
    Huang Y; Li T; Eatherton A; Mitchell WL; Rong N; Ye L; Yang XJ; Jin S; Ding Y; Zhang J; Li Y; Wu Y; Jin Y; Sang Y; Cheng Z; Browne ER; Harrison DC; Hussain I; Wan Z; Hall A; Lau LF; Matsuoka Y
    Neuropharmacology; 2013 Jul; 70():278-86. PubMed ID: 23485401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice.
    Salahudeen MS; Nishtala PS
    Saudi Pharm J; 2017 Feb; 25(2):165-175. PubMed ID: 28344466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models.
    Krzyzanski W; Chakraborty A; Jusko WJ
    Chronobiol Int; 2000 Jan; 17(1):77-93. PubMed ID: 10672436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice.
    Thakker DR; Sankaranarayanan S; Weatherspoon MR; Harrison J; Pierdomenico M; Heisel JM; Thompson LA; Haskell R; Grace JE; Taylor SJ; Albright CF; Shafer LL
    J Neurosci; 2015 Apr; 35(17):6931-6. PubMed ID: 25926467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide].
    Best JD; Jay MT; Otu F; Ma J; Nadin A; Ellis S; Lewis HD; Pattison C; Reilly M; Harrison T; Shearman MS; Williamson TL; Atack JR
    J Pharmacol Exp Ther; 2005 May; 313(2):902-8. PubMed ID: 15743924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.